1Schiffrin EL, Touyz RM. From bedside to bench to bedside: role of reninangiotensin-aldosterone system in remodeling of resistance arteries in hypertension[J].Am J Physiol Heart Circ Physiol,2004,287:H435-446.
2Uematsu M, Suzuki H, Delano FA, et al. The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis[J].Microcirculation,2002,9:259-276.
3Ishibashi M, Hiasa K, Zhao Q, et al. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling[J].Circ Res,2004,94:1203-1210.
4Tham DM, Martin-McNulty B, Wang YX, et al. angiotensin Ⅱ is associated with activation of NF-κappaB-mediated genes and downregulation of PPARs[J].Physiol Genomics,2002,11:21-30.
5Koh KK, Ahn JY, Han SH, et al. Pleiotropic effects of angiotensin Ⅱ receptor blocker in hypertensive patients[J].J Am Coll Cardiol,2003,42:905-910.
6Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension[J].Histochem Cell Biol,2004,122:339-352.
7Schiffrin EL. Beyond blood pressure: the endothelium and atherosclerosis progression[J].Am J Hypertens,2002,15:S115-122.
8Nathan C. Points of control in inflammation[J].Nature,2002,420:846-853.
9杨光华.病理学[M](第五版)[M].北京:人民卫生出版社,2002..
10Tracey KJ. The inflammatory reflex[J].Nature,2002,420:853-860.
